The Lockwood Group, LLC

Senior Associate Scientific Director - Publications

London, England, United Kingdom

Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceutical, Biotech, Medical Devices, Medical CommunicationsIndustries

Requirements

Candidates must possess an advanced degree in science, such as a PhD, PharmD, or MD, and preferably hold a Certified Medical Professional Plus (CMPP). A minimum of four years of relevant job experience in medical publications, including manuscripts, posters, abstracts, podium presentations, scientific platforms, and publication extenders is required. Experience with established professional medical editorial processes, such as AMA style, and ethical guideline working knowledge, including ICMJE and GPP2022, is also necessary. Experience in oncology, hematology, cardiovascular medicine, and/or respiratory medicine is a plus.

Responsibilities

The Senior Associate Scientific Director will develop high-quality, medically accurate content for assigned projects under the supervision of a Senior Scientific Director, working with them to support the achievement of brand goals. This role involves engaging with Key Opinion Leaders (KOLs) and Healthcare Professionals (HCPs), managing resources and timelines for assigned projects, partnering with client services to deliver projects on time and within budget, conducting background research, data-checking, and reference annotation, and performing other content-related tasks.

Skills

Medical Publications
Manuscripts
Posters
Abstracts
Podium Presentations
Scientific Platforms
Reference Annotation
Data-Checking
Background Research
Scientific Content Development
Client Collaboration
Project Management

The Lockwood Group, LLC

Healthcare consulting for drug development support

About The Lockwood Group, LLC

The Lockwood Group provides consulting services specifically for the healthcare and pharmaceutical industries, focusing on clients in the later stages of drug development, particularly after Phase 2 clinical trials. The company assists pharmaceutical and biotech firms by creating strategic publication plans that communicate scientific data and research findings accurately and in compliance with regulatory standards. They also support clients during the prelaunch phase of their products by identifying market needs and collaborating through the launch process to ensure success. A unique aspect of The Lockwood Group is its medical animation affiliate, Random42, which produces engaging and scientifically accurate visual content to help convey complex information. Their business model is based on service fees for consulting and project work, with a commitment to delivering high-quality communications and strategic support to help clients thrive in the competitive healthcare landscape.

Key Metrics

Stamford, ConnecticutHeadquarters
2007Year Founded
ACQUISITIONCompany Stage
Consulting, HealthcareIndustries
201-500Employees

Benefits

Remote Work Options
Flexible Work Hours

Risks

Emerging firms using AI-driven content creation threaten market share.
Pharmaceutical companies developing in-house teams may reduce demand for external services.
Tightening EU regulatory standards could increase compliance costs.

Differentiation

Specializes in healthcare and pharmaceutical sectors, focusing on advanced drug development stages.
Offers strategic publication plans tailored to specific audiences and regulatory standards.
Provides commercial support during prelaunch, launch, and post-launch phases.

Upsides

Increased demand for digital health solutions boosts growth in medical communications.
Rise of personalized medicine creates opportunities for specialized communication strategies.
Integration of AI enhances publication strategies and data analysis capabilities.

Land your dream remote job 3x faster with AI